144 related articles for article (PubMed ID: 33669477)
21. Diagnosis of Cystic Fibrosis in Nonscreened Populations.
Sosnay PR; White TB; Farrell PM; Ren CL; Derichs N; Howenstine MS; Nick JA; De Boeck K
J Pediatr; 2017 Feb; 181S():S52-S57.e2. PubMed ID: 28129813
[TBL] [Abstract][Full Text] [Related]
22. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Padoan R; Bassotti A; Seia M; Corbetta C
Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
[TBL] [Abstract][Full Text] [Related]
23. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients.
Decaestecker K; Decaestecker E; Castellani C; Jaspers M; Cuppens H; De Boeck K
Eur Respir J; 2004 May; 23(5):679-84. PubMed ID: 15176679
[TBL] [Abstract][Full Text] [Related]
24. Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case report.
Welsner M; Straßburg S; Taube C; Sutharsan S
BMC Pulm Med; 2019 Apr; 19(1):76. PubMed ID: 30975115
[TBL] [Abstract][Full Text] [Related]
25. Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.
Donaldson SH; Pilewski JM; Griese M; Cooke J; Viswanathan L; Tullis E; Davies JC; Lekstrom-Himes JA; Wang LT;
Am J Respir Crit Care Med; 2018 Jan; 197(2):214-224. PubMed ID: 28930490
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostics of cystic fibrosis in adults].
Fila L; Grandcourtová A; Bartáková LV; Antušová Z; Pokojová E; Herout V; Jakubec P; Bittenglová R; Marel M
Vnitr Lek; 2016; 62(5):360-4. PubMed ID: 27319228
[TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
28. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
[TBL] [Abstract][Full Text] [Related]
29. The diagnosis of cystic fibrosis.
De Boeck K; Vermeulen F; Dupont L
Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
[TBL] [Abstract][Full Text] [Related]
30. [Genotype-phenotype correlation in a sample of Mexican patients with cystic fibrosis].
Yokoyama E; Lezana JL; Vigueras-Villaseñor RM; Rojas-Castañeda J; Saldaña-Álvarez Y; Orozco L; Chávez-Saldaña M
Rev Invest Clin; 2013; 65(6):491-9. PubMed ID: 24687356
[TBL] [Abstract][Full Text] [Related]
31. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
33. Differences in Outcomes between Early and Late Diagnosis of Cystic Fibrosis in the Newborn Screening Era.
Coffey MJ; Whitaker V; Gentin N; Junek R; Shalhoub C; Nightingale S; Hilton J; Wiley V; Wilcken B; Gaskin KJ; Ooi CY
J Pediatr; 2017 Feb; 181():137-145.e1. PubMed ID: 27837951
[TBL] [Abstract][Full Text] [Related]
34. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
35. The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype.
Duguépéroux I; De Braekeleer M
Eur Respir J; 2005 Mar; 25(3):468-73. PubMed ID: 15738290
[TBL] [Abstract][Full Text] [Related]
36. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis.
Wu HX; Zhu M; Xiong XF; Wei J; Zhuo KQ; Cheng DY
Adv Ther; 2019 Feb; 36(2):451-461. PubMed ID: 30554331
[TBL] [Abstract][Full Text] [Related]
38. What can the CF registry tell us about rare CFTR-mutations? A Belgian study.
De Wachter E; Thomas M; Wanyama SS; Seneca S; Malfroot A
Orphanet J Rare Dis; 2017 Aug; 12(1):142. PubMed ID: 28830496
[TBL] [Abstract][Full Text] [Related]
39. Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor.
Rubin JL; O'Callaghan L; Pelligra C; Konstan MW; Ward A; Ishak JK; Chandler C; Liou TG
Ther Adv Respir Dis; 2019; 13():1753466618820186. PubMed ID: 30803355
[TBL] [Abstract][Full Text] [Related]
40. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
